These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21833439)

  • 1. A severe haematologic adverse reaction after high dosage radioiodine therapy following blood stem cell mobilization with growth factors.
    Freesmeyer M
    Nuklearmedizin; 2011; 50(4):N34-6. PubMed ID: 21833439
    [No Abstract]   [Full Text] [Related]  

  • 2. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 3. Cytokinesis-block micronucleus test in patients undergoing radioiodine therapy for differentiated thyroid carcinoma.
    Popova L; Hadjidekova V; Hadjieva T; Agova S; Vasilev I
    Hell J Nucl Med; 2005; 8(1):54-7. PubMed ID: 15886755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodine therapy for papillary and follicular thyroid carcinoma.
    Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancytopenia after repeated radioiodine treatment on metastatic thyroid cancer to bone.
    Tanigawa K; Yamashita S; Nagataki S
    Chin Med J (Engl); 1995 Oct; 108(10):796-7. PubMed ID: 8565674
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of high-dose radioiodine treatment on lacrimal gland function in patients with differentiated thyroid carcinoma.
    Fard-Esfahani A; Mirshekarpour H; Fallahi B; Eftekhari M; Saghari M; Beiki D; Ansari-Gilani K; Takavar A
    Clin Nucl Med; 2007 Sep; 32(9):696-9. PubMed ID: 17710021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
    Nakada K; Ishibashi T; Takei T; Hirata K; Shinohara K; Katoh S; Zhao S; Tamaki N; Noguchi Y; Noguchi S
    J Nucl Med; 2005 Feb; 46(2):261-6. PubMed ID: 15695785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioidine therapy temporarily increases circulating endothelial cells and decreases endothelial progenitor cells.
    Palumbo B; Palumbo R; Sinzinger H
    Nucl Med Rev Cent East Eur; 2003; 6(2):123-6. PubMed ID: 14737726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Airway complication occurring during radioiodine treatment for Graves' disease.
    Kinuya S; Yoneyama T; Michigishi T
    Ann Nucl Med; 2007 Aug; 21(6):367-9. PubMed ID: 17705018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes.
    Watanabe N; Kanegane H; Kinuya S; Shuke N; Yokoyama K; Kato H; Tomizawa G; Shimizu M; Funada H; Seto H
    J Nucl Med; 2004 Apr; 45(4):608-11. PubMed ID: 15073256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in the blood picture after radioiodine therapy of thyroid cancer].
    Grünwald F; Schomburg A; Menzel C; Steinecker S; Späth G; Bockisch A; Fimmers R; Hotze AL; Biersack HJ
    Med Klin (Munich); 1994 Oct; 89(10):522-8. PubMed ID: 7808352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioiodine therapy of euthyroid multinodular goitres.
    Manders JM; Corstens FH
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S466-70. PubMed ID: 12192547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothyroidism following radioiodine treatment of thyrotoxicosis.
    Staffurth JS
    J R Coll Physicians Lond; 1987 Jan; 21(1):55-7. PubMed ID: 3820156
    [No Abstract]   [Full Text] [Related]  

  • 14. Radioiodine therapy in differentiated thyroid cancer: a nuclear medicine perspective.
    Clarke SE
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):430-7. PubMed ID: 20537878
    [No Abstract]   [Full Text] [Related]  

  • 15. Radioiodine therapy and thyrostatic drugs and iodine.
    Moka D; Dietlein M; Schicha H
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S486-91. PubMed ID: 12192550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequential comparison of seed loss and prostate dosimetry of stranded seeds with loose seeds in 125I permanent implant for low-risk prostate cancer.
    Saibishkumar EP; Borg J; Yeung I; Cummins-Holder C; Landon A; Crook J
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):61-8. PubMed ID: 18823713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy.
    Moman MR; van der Poel HG; Battermann JJ; Moerland MA; van Vulpen M
    Brachytherapy; 2010; 9(2):119-25. PubMed ID: 19850536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term hematologic changes caused by radioiodine treatment of thyroid cancer. I. Peripheral blood changes].
    Schober O; Günter HH; Schwarzrock R; Hundeshagen H
    Strahlenther Onkol; 1987 Jul; 163(7):464-74. PubMed ID: 3616905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioiodine therapy of thyroid autonomy.
    Reiners C; Schneider P
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S471-8. PubMed ID: 12192548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Grave's Eye disease developing following radioiodine treatment for toxic nodular goitre.
    Tahrani AA; Rangan S; Moulik P
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):471-3. PubMed ID: 17647147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.